AI chatbots like ChatGPT were considered to be disruptive technologies when they were unveiled shortly after the upheaval of the pandemic. But what happens when the disruptor is disrupted? The announcement of the cut-price competitor DeepSeek from China’s Hangzhou DeepSeek Artificial Intelligence Co. Ltd shows how even AI giants like Nvidia and OpenAI are themselves […]
2025 has already begun with drama in the U.S., as Los Angeles recovers from deadly wildfires and Donald Trump is sworn in for his second presidency. And so it was that the mood going into the annual JP Morgan Healthcare Conference was clouded by uncertainty. With its timing in January, JPM is often seen as […]
#AI has been making the headlines again this week, with a bold announcement from the UK government that it could be used to fix the many potholes that pepper Britain’s roads. But beyond politics, there’s an ongoing narrative in life sciences about the growing role of AI across the clinical development process. Perhaps the most […]
Bioptimus announces a $76M funding milestone, with the latest injection of $41M led by Cathay Innovation less than 12 months from its initial seed round Since the successful release of the largest AI foundation model for pathology in July, the company has been continuing its groundbreaking work and is now poised to release a breakthrough […]
Licensing agreement gives Elevation Oncology access to Synaffix’s ADC technology for one program in combination with SYNstatin E™ Elevation Oncology nominates a novel HER3 ADC candidate EO-1022 leveraging its antibody as well as Synaffix’s proprietary ADC development technologies AMSTERDAM, THE NETHERLANDS, 12 December 2024 — Synaffix B.V., a Lonza company (SIX:LONN) focused on commercializing its […]
